MIRM logo

Mirum Pharmaceuticals, Inc. (MIRM) Selling, General & Administrative Expenses

Annual SG&A:

$0.00-$145.88M(-100.00%)
December 31, 2024

Summary

  • As of today, MIRM annual SG&A is $0.00, with the most recent change of -$145.88 million (-100.00%) on December 31, 2024.
  • During the last 3 years, MIRM annual SG&A has fallen by -$59.22 million (-100.00%).
  • MIRM annual SG&A is now -100.00% below its all-time high of $145.88 million, reached on December 31, 2023.

Performance

MIRM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

Quarterly SG&A:

$63.29M+$5.58M(+9.67%)
June 30, 2025

Summary

  • As of today, MIRM quarterly SG&A is $63.29 million, with the most recent change of +$5.58 million (+9.67%) on June 30, 2025.
  • Over the past year, MIRM quarterly SG&A has increased by +$14.08 million (+28.61%).
  • MIRM quarterly SG&A is now at all-time high.

Performance

MIRM Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

TTM SG&A:

-$2.59B-$58.56M(-2.32%)
June 30, 2025

Summary

  • As of today, MIRM TTM SG&A is -$2.59 billion, with the most recent change of -$58.56 million (-2.32%) on June 30, 2025.
  • Over the past year, MIRM TTM SG&A has dropped by -$2.77 billion (-1557.64%).
  • MIRM TTM SG&A is now -11005.55% below its all-time high of -$23.30 million.

Performance

MIRM TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

MIRM Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-100.0%+28.6%-1557.6%
3Y3 Years-100.0%+201.8%-3484.4%
5Y5 Years-100.0%+1155.2%-10000.0%

MIRM Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.0%at lowat high+181.1%-110.8%at low
5Y5-Year-100.0%at lowat high+1004.1%-528.9%at low
All-TimeAll-Time-100.0%at lowat high>+9999.0%>-9999.0%at low

MIRM Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$63.29M(+9.7%)
$228.37M(+6.6%)
Mar 2025
-
$57.71M(+1.5%)
$214.29M(+6.0%)
Dec 2024
$0.00(-100.0%)
$56.83M(+12.4%)
$202.22M(+5.6%)
Sep 2024
-
$50.55M(+2.7%)
$191.57M(+7.9%)
Jun 2024
-
$49.21M(+7.8%)
$177.56M(+10.1%)
Mar 2024
-
$45.64M(-1.2%)
$161.30M(+10.6%)
Dec 2023
$145.88M(+63.8%)
$46.18M(+26.4%)
$145.88M(+15.6%)
Sep 2023
-
$36.53M(+10.9%)
$126.16M(+12.5%)
Jun 2023
-
$32.95M(+9.0%)
$112.15M(+12.0%)
Mar 2023
-
$30.22M(+14.2%)
$100.17M(+12.5%)
Dec 2022
$89.07M(+50.4%)
$26.47M(+17.6%)
$89.07M(+9.1%)
Sep 2022
-
$22.51M(+7.4%)
$81.63M(+6.7%)
Jun 2022
-
$20.97M(+9.7%)
$76.47M(+11.1%)
Mar 2022
-
$19.12M(+0.4%)
$68.86M(+16.3%)
DateAnnualQuarterlyTTM
Dec 2021
$59.22M(+161.0%)
$19.04M(+9.7%)
$59.22M(+24.9%)
Sep 2021
-
$17.35M(+30.0%)
$47.41M(+32.5%)
Jun 2021
-
$13.35M(+40.9%)
$35.79M(+30.2%)
Mar 2021
-
$9.48M(+31.2%)
$27.48M(+21.1%)
Dec 2020
$22.69M(+93.1%)
$7.22M(+26.0%)
$22.69M(+14.9%)
Sep 2020
-
$5.73M(+13.7%)
$19.74M(+11.4%)
Jun 2020
-
$5.04M(+7.5%)
$17.72M(+17.2%)
Mar 2020
-
$4.69M(+9.7%)
$15.12M(+28.7%)
Dec 2019
$11.75M(+1908.9%)
$4.28M(+15.4%)
$11.75M(+57.2%)
Sep 2019
-
$3.71M(+51.7%)
$7.47M(+95.2%)
Jun 2019
-
$2.44M(+85.1%)
$3.83M(+176.8%)
Mar 2019
-
$1.32M(+2030.6%)
$1.38M(+2130.6%)
Dec 2018
$585.00K
-
-
Sep 2018
-
$62.00K
$62.00K

FAQ

  • What is Mirum Pharmaceuticals, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. annual SG&A year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. TTM SG&A year-on-year change?

What is Mirum Pharmaceuticals, Inc. annual SG&A?

The current annual SG&A of MIRM is $0.00

What is the all-time high annual SG&A for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high annual SG&A is $145.88M

What is Mirum Pharmaceuticals, Inc. annual SG&A year-on-year change?

Over the past year, MIRM annual SG&A has changed by -$145.88M (-100.00%)

What is Mirum Pharmaceuticals, Inc. quarterly SG&A?

The current quarterly SG&A of MIRM is $63.29M

What is the all-time high quarterly SG&A for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high quarterly SG&A is $63.29M

What is Mirum Pharmaceuticals, Inc. quarterly SG&A year-on-year change?

Over the past year, MIRM quarterly SG&A has changed by +$14.08M (+28.61%)

What is Mirum Pharmaceuticals, Inc. TTM SG&A?

The current TTM SG&A of MIRM is -$2.59B

What is the all-time high TTM SG&A for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high TTM SG&A is -$23.30M

What is Mirum Pharmaceuticals, Inc. TTM SG&A year-on-year change?

Over the past year, MIRM TTM SG&A has changed by -$2.77B (-1557.64%)
On this page